Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Carcinoma in Situ

dehydroepiandrosterone sulfate has been researched along with Carcinoma in Situ in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baffico, M; Cappi, C; De Cassan, P; Foppiani, L; Giusti, M; Lando, G; Minuto, F; Patrosso, MC; Penco, S; Vitali, A1
Carruth, JA; Colquhoun-Flannery, W1

Other Studies

2 other study(ies) available for dehydroepiandrosterone sulfate and Carcinoma in Situ

ArticleYear
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.
    Journal of endocrinological investigation, 2004, Volume: 27, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Carcinoma in Situ; Cystic Fibrosis Transmembrane Conductance Regulator; Dehydroepiandrosterone Sulfate; Dexamethasone; Follicle Stimulating Hormone; Glucocorticoids; Humans; Male; Mutation; Obesity; Oligospermia; Steroid 21-Hydroxylase; Testicular Neoplasms; Testosterone; Vas Deferens

2004
Low adrenal androgen output in patients with abnormal laryngeal epithelium.
    Clinical otolaryngology and allied sciences, 1996, Volume: 21, Issue:5

    Topics: Aged; Biomarkers, Tumor; Biopsy; Carcinoma in Situ; Dehydroepiandrosterone Sulfate; Humans; Laryngeal Neoplasms; Laryngitis; Luteinizing Hormone; Male; Pilot Projects; Testosterone; Vocal Cords

1996